In response to the House of Commons Science and Technology Committee report, ‘Leaving the EU: implications and opportunities for science and research, Aisling Burnand CEO of the Association of Medical Research Charities (AMRC) said:
“We welcome the Committee’s report published this morning and its recommendations that chime with not only our position, but with those across the sector. It is particularly encouraging that the Committee picked up from the evidence we submitted that patients must not face delays in accessing novel treatments.
“Uncertainty about the future of the UK’s world class science base is not only a major concern for medical research in terms of attracting those essential to the research field and inward investment but also to those who benefit from it the most – patients. There must be no adverse impact on people affected by disease and ill health – including their ability to take part in clinical trials and access to treatments.
To ensure that the UK’s vibrant medical research sector can continue to grow and thrive, the Government should act to protect patients by safeguarding the potential for pan-EU collaboration to speed the discovery and understanding of diseases and ill-health. Access to treatments through an aligned and compatible regulatory framework will minimise delays in accessibility for those who need new therapies. The UK currently attracts people who conduct some of the most innovative and ground-breaking research in the world and we ask the government to implement a system which will not hamper the ability to work across the EU.”
The full report can be found here.
For further information please contact Nisha Tailor, firstname.lastname@example.org, 0207 685 2626.
NOTES TO EDITORS
- The Association of Medical Research Charities (AMRC) is the national membership organisation for the health and medical research charity world, influencing the policy and research environments by harnessing the collective strengths of our members, to demonstrate the sector’s positive impact on health and wellbeing.
- AMRC has 135 members which include the largest health and medical charities in the UK: the British Heart Foundation, Cancer Research UK, and the Wellcome Trust. All members, large and small, work to the same high standards ensuring that every pound they spend on research is invested in lifesaving research of the very highest quality.
- In 2015, health and medical research charities:
- Invested £1.4bn in research here in the UK
- Financed capital projects worth £129m
- Funded the salaries of at least 15,000 researchers.